Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

• Status: Completed
• Trial end date: 2012-12-01

Summary

The purpose of this study is to assess efficacy and safety of belinostat in combination with carboplatin and paclitaxel in patients with previously untreated carcinoma of unknown primary.

• Phase: Phase 2

Details

• Lead Sponsor: Onxeo
• Collaborator: Spectrum Pharmaceuticals, Inc
• Treatments: Albumin-Bound Paclitaxel; Belinostat; Carboplatin; Paclitaxel